Cresset Biomolecular Discovery Limited is a specialized software development company focused on providing computational chemistry solutions to the pharmaceutical industry. Established in 2001 and currently active, Cresset offers a range of services designed to significantly accelerate drug discovery and development. The company’s core expertise lies in molecular modeling and simulation, utilizing advanced algorithms and software to assist researchers in understanding and predicting molecular interactions. Cresset’s primary service area centers around structure-based drug design, enabling clients to efficiently explore and optimize potential drug candidates. They specialize in providing customized solutions, including molecular dynamics simulations, docking studies, and virtual screening. The company’s capabilities extend to various stages of drug development, from initial target identification to lead optimization and preclinical research. Cresset’s international presence is a key element of its strategy, facilitating collaboration with partners globally. The company employs a team of skilled scientists and software engineers, and actively recruits individuals with expertise in computational chemistry and related fields. They are rated as a Skilled Worker and have a Worker rating, indicating a commitment to high-quality work and a focus on delivering impactful results. The company’s SIC codes include: - 62012: Business and domestic software development; - 72190: Other research and experimental development on natural sciences and engineering.

Cresset Biomolecular Discovery Limited is a specialized software development company focused on providing computational chemistry solutions to the pharmaceutical industry. Established in 2001 and currently active, Cresset offers a range of services designed to significantly accelerate drug discovery and development. The company’s core expertise lies in molecular modeling and simulation, utilizing advanced algorithms and software to assist researchers in understanding and predicting molecular interactions. Cresset’s primary service area centers around structure-based drug design, enabling clients to efficiently explore and optimize potential drug candidates. They specialize in providing customized solutions, including molecular dynamics simulations, docking studies, and virtual screening. The company’s capabilities extend to various stages of drug development, from initial target identification to lead optimization and preclinical research. Cresset’s international presence is a key element of its strategy, facilitating collaboration with partners globally. The company employs a team of skilled scientists and software engineers, and actively recruits individuals with expertise in computational chemistry and related fields. They are rated as a Skilled Worker and have a Worker rating, indicating a commitment to high-quality work and a focus on delivering impactful results. The company’s SIC codes include: - 62012: Business and domestic software development; - 72190: Other research and experimental development on natural sciences and engineering.